Clinical Trials Directory

Trials / Unknown

UnknownNCT03889964

Exercise Capacity in COPD

Reduced Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease -Relevance of Cardiovascular Comorbidities

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Klinik für Kardiologie, Pneumologie und Angiologie · Academic / Other
Sex
All
Age
40 Years – 40 Years
Healthy volunteers

Summary

In this study, cardiopulmonary exercise will be assessed to characterize the relevance of severity of COPD and coexisting cardiovascular comorbidities for exercise capacity.

Detailed description

In patients with chronic obstructive pulmonary disease (COPD) the interpretation of dyspnoea also needs to consider coexisting cardiovascular disease. Cardiopulmonary exercise testing (CPET) is used to characterize pulmonary and cardiac function and limitations during exercise. The investigators hypothesise that cardiopulmonary exercise is reduced in COPD patients with coexisting cardiovascular disease as well as in more symptomatic patients and in patients with frequent exacerbations. For this purpose, 100 patients with with stable COPD are characterized by clinical characteristics, laboratory tests, lung function, electrocardiography, echocardiography and cardiopulmonary exercise testing.

Conditions

Interventions

TypeNameDescription
OTHERMeasurement of lung function, electrocardiography, echocardiography and cardiopulmonary exercise testingMeasurement of lung function, electrocardiography, echocardiography and cardiopulmonary exercise testing

Timeline

Start date
2019-03-01
Primary completion
2020-12-01
Completion
2020-12-01
First posted
2019-03-26
Last updated
2020-02-11

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03889964. Inclusion in this directory is not an endorsement.

Exercise Capacity in COPD (NCT03889964) · Clinical Trials Directory